The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study
Open accessAbstract
AIMS: HIV-infected patients receiving combination antiretroviral therapy may experience metabolic complications, potentially increasing their risk of cardiovascular diseases (CVDs). Furthermore, exposures to some antiretroviral drugs seem to be independently associated with increased CVD risk. We aimed to develop cardiovascular risk-assessment models tailored to HIV-infected patients. METHODS AND RESULTS: Prospective multinational cohort study. The data set included 22,625 HIV-infected patients from 20 countries in Europe and Australia who were free of CVD at entry into the Data collection on Adverse Effects of Anti-HIV Drugs Study. Using cross-validation methods, separate models were developed to predict the risk of myocardial infarction, coronary heart disease, and a composite CVD endpoint. Model performance was compared with the Framingham score. The models included age, sex, systolic blood pressure, smoking status, family history of CVD, diabetes, total cholesterol, HDL cholesterol and indinavir, lopinavir/r and abacavir exposure. The models performed well with area under the receiver operator curve statistics of 0.783 (range 0.642-0.820) for myocardial infarction, 0.776 (0.670-0.818) for coronary heart disease and 0.769 (0.695-0.824) for CVD. The models estimated more accurately the outcomes in the subgroups than the Framingham score. CONCLUSION: Risk equations developed from a population of HIV-infected patients, incorporating routinely collected cardiovascular risk parameters and exposure to individual antiretroviral therapy drugs, might be more useful in estimating CVD risks in HIV-infected persons than conventional risk prediction models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While it predicts cardiovascular events, the thresholds may vary from HIV-uninfected populations and may under-estimate risk and HIV-specific indices (e.g., DAD CV index) that may be more accurate (62–64)”
From HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Office of AIDS Research by the HIV and Aging Working Group (2012) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A.-M., & Pająk, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,260
CD4+ Count–Guided Interruption of Antiretroviral Treatment
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250
Cardiovascular disease risk profiles
Anderson, K. M., Odell, P. M., Wilson, P. W. F., & Kannel, W. B. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90861-b · Cited by 2,163
D'Agostino, R. B., Grundy, S., Sullivan, L. M., Wilson, P., & for the CHD Risk Prediction Group (2001) · JAMA · doi:10.1001/jama.286.2.180 · Cited by 2,108
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
El-Sadr, W. M., & The Data Collection On Adverse Events Of Anti-HIV Drugs (DAD) Study Group (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030218 · Cited by 1,677
Self-citationTriant, V. A., Lee, H., Hadigan, C., & Grinspoon, S. K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2190 · Cited by 1,613
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521
Friis‐Møller, N., Weber, R. K., Reiss, P., Thiébaut, R., Kirk, O., Monforte, A. D., Pradier, C., Morfeldt, L., Mateu, S., Law, M. G., et al. (2003) · AIDS · doi:10.1097/00002030-200305230-00010 · Cited by 1,076
Self-citationTeo, K. K., Ôunpuu, S., Hawken, S., Pandey, M., Valentín, V., Hunt, D. U., Díaz, R., Rashed, W. A., Freeman, R. V., Jiang, L., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69249-0 · Cited by 999
Barrett-Connor, E. L. (1991) · JAMA · doi:10.1001/jama.265.5.627 · Cited by 679
Worm, S. W., Sabin, C. A., Weber, R. K., Reiss, P., El-Sadr, W. M., Dabis, F., Wit, S. D., Law, M. G., Monforte, A. D., Friis‐Møller, N., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/649897 · Cited by 644
Self-citationMary‐Krause, M., Cotte, L., Simon, A., Partisani, M., & Costagliola, D. G. (2003) · AIDS · doi:10.1097/00002030-200311210-00010 · Cited by 563
Protease inhibitors and cardiovascular outcomes in patients with HIV-1
Holmberg, S. D., Moorman, A. C., Williamson, J. M., Tong, T. C., Ward, D. J., Wood, K. C., Greenberg, A. E., & Janssen, R. S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11672-2 · Cited by 487
Lee, W. L., Cheung, A. M., Cape, D., & Zinman, B. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.962 · Cited by 442
Obel, N., Thomsen, H. F., Kronborg, G., Larsen, C. S., Hildebrandt, P. R., Sørensen, H. T., & Gerstoft, J. (2007) · Clinical Infectious Diseases · doi:10.1086/518285 · Cited by 331
Groups, T. S. A. T. D. S. (2008) · AIDS · doi:10.1097/qad.0b013e32830fe35e · Cited by 327
Law, M. G., Friis‐Møller, N., El-Sadr, W. M., Weber, R. K., Reiss, P., Monforte, A. D., Thiébaut, R., Morfeldt, L., Wit, S. D., Pradier, C., et al. (2006) · HIV Medicine · doi:10.1111/j.1468-1293.2006.00362.x · Cited by 295
Self-citationCardio- and cerebrovascular events in HIV-infected persons
The Writing Committee (2004) · AIDS · doi:10.1097/00002030-200409030-00010 · Cited by 250
MAY, M. T. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69152-6 · Cited by 226
Martin, A. M., Bloch, M., Amin, J., Baker, D., Cooper, D. A., Emery, S., & Carr, A. D. (2009) · Clinical Infectious Diseases · doi:10.1086/644769 · Cited by 222
Ten-Year Predicted Coronary Heart Disease Risk in HIV-Infected Men and Women
Kaplan, R. C., Kingsley, L., Sharrett, A. R., Li, X., Lazar, J., Tien, P. C., Mack, W. J., Cohen, M. H., Jacobson, L. P., & Gange, S. J. (2007) · Clinical Infectious Diseases · doi:10.1086/521935 · Cited by 219
Lundgren, J., Battegay, M., Behrens, G., De Wit, S., Guaraldi, G., Katlama, C., Martinez, E., Nair, D., Powderly, W., Reiss, P., et al. (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00534.x · Cited by 210
Self-citationThomsen, T. F., McGee, D., Davidsen, M., & Jørgensen, T. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.4.817 · Cited by 183
Hsue, P. Y., Hunt, P. W., Wu, Y., Schnell, A., Ho, J. E., Hatano, H., Xie, Y., Martin, J. N., Ganz, P., & Deeks, S. G. (2009) · AIDS · doi:10.1097/qad.0b013e32832e7140 · Cited by 168
Protease inhibitor exposure and increased risk of cardiovascular disease in HIV‐infected patients
Iloeje, U., Yuan, Y., L’Italien, G. J., Mauskopf, J., Holmberg, S. D., Moorman, A. C., Wood, K., & Moore, R. D. (2005) · HIV Medicine · doi:10.1111/j.1468-1293.2005.00265.x · Cited by 137
Royston, P. J., Parmar, M., & Sylvester, R. J. (2004) · Statistics in Medicine · doi:10.1002/sim.1691 · Cited by 129
Lundgren, J. D., Mocroft, A., Gatell, J. M., Ledergerber, B., Monforte, A. D., Hermans, P., Goebel, F., Blaxhult, A., Kirk, O., Phillips, A. N., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/338267 · Cited by 129
Self-citationCooper, J. A., Miller, G. J., & Humphries, S. E. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.026 · Cited by 122
Worm, S. W., Wit, S. D., Weber, R. K., Sabin, C. A., Reiss, P., El‐Sadr, W., Monforte, A. D., Kirk, O., Fontas, É., Dabis, F., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.790857 · Cited by 99
Self-citationMay, M., Royston, P., Egger, M., Justice, A., & Sterne, J. A. C. (2004) · Statistics in Medicine · doi:10.1002/sim.1825 · Cited by 81
Visser, C., Bilo, H. J. G., Thomsen, T. F., Groenier, K. H., & Jong, B. M. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01137.x · Cited by 67
From Hayflick to Walford: the role of T cell replicative senescence in human aging
Effros, R. B. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.03.004 · Cited by 61
Chirovsky, D. R., Fedirko, V., Cui, Y. A., Sazonov, V., & Barter, P. J. (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32832c8891 · Cited by 58
Bénard, A., Tessier, J. F., Rambeloarisoa, J., Bonnet, F., Fossoux, H., Neau, D., Dutronc, H., Lazaro, E., Dabis, F., & Chêne, G. (2006) · PubMed · Cited by 42
Kristoffersen, U. S., Kofoed, K. F., Kronborg, G., Benfield, T., Kjær, A., & Lebech, A. (2009) · HIV Medicine · doi:10.1111/j.1468-1293.2009.00733.x · Cited by 34
HeartScore®: a new web-based approach to European cardiovascular disease risk management
Thomsen, T. F. (2005) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000186617.29992.11 · Cited by 32
May, M., Sterne, J. A. C., Shipley, M. J., Brunner, E. J., D’Agostino, R. B., Whincup, P. H., Ben‐Shlomo, Y., Carr, A. D., Ledergerber, B., Lundgren, J. D., et al. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym135 · Cited by 27
Self-citationPatel, N., Talwar, A., Reichert, V. C., Brady, T., Jain, M., & Kaplan, M. H. (2006) · PubMed · doi:10.1016/j.coem.2005.10.012 · Cited by 27
Research works printed but not linked: 5
- Lang S, 2009, Impact of specific NRTI and PI exposure on the risk of myocardial infarction: a case-control study nested within FHDH ANRS CO4
- Benard A, 2006, Int J Tuberc Lung Dis, 10, 378
- Patel N, 2006, Clin Occup Environ Med, 5, 193
- Barrett-Connor EL, 1991, JAMA, 265, 627, 10.1001/jama.1991.03460050081025 · DOI
- Friis-Moller N, 2007, Predicting the Risk of Coronary Heart Disease in HIV-infected Patients: The D:A:D Risk Equation
Cited by
Sorted by citations
HIV Infection and the Risk of Acute Myocardial Infarction
Freiberg, M. S., Chang, C.-C. H., Kuller, L. H., Skanderson, M., Lowy, E., Kraemer, K. L., Butt, A. A., Goetz, M. B., Leaf, D. A., Oursler, K. A., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.3728 · Cited by 1,340
Shah, A. S. V., Stelzle, D., Lee, K. K., Beck, E. J., Alam, S., Clifford, S., Longenecker, C. T., Strachan, F., Bagchi, S., Whiteley, W., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.033369 · Cited by 975
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784
Feinstein, M. J., Hsue, P. Y., Benjamin, L. A., Bloomfield, G. S., Currier, J. S., Freiberg, M. S., Grinspoon, S. K., Levin, J., Longenecker, C. T., & Post, W. S. (2019) · Circulation · doi:10.1161/cir.0000000000000695 · Cited by 673
High, K. P., Brennan-Ing, M., Clifford, D. B., Cohen, M. H., Currier, J., Deeks, S. G., Deren, S., Effros, R. B., Gebo, K., Goronzy, J. J., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31825a3668 · Cited by 522
Metadata
- Authors
- Friis-Møller, N., Thiébaut, R., Reiss, P., Weber, R., D'Arminio Monforte, A., De Wit, S., El-Sadr, W., Fontas, E., Worm, S., Kirk, O., Phillips, A., Sabin, C. A., Lundgren, J. D., Law, M. G., & DAD study group
- Affiliations
- Copenhagen HIV Programme (CHIP), University of Copenhagen/Faculty of Health Science, Copenhagen, Denmark
- Inserm (FR)
- Amsterdam UMC Location University of Amsterdam (NL)
- University Hospital Zurich (CH)
- ICONA, Hospital San Paolo, University of Milan, Italy
- Saint-Pierre Cohort, CHU Saint-Pierre Hospital, Brussels, Belgium
- Columbia University Irving Medical Center (US)
- Nice Cohort, CHU Nice Hopital de l'Archet, Nice, France
- University of Copenhagen (DK)
- The Royal Free Hospital (GB)
- AHOD, National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia
- ORCID
- Venue
- European Journal of Cardiovascular Prevention & Rehabilitation
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-10
- Volume
- 17
- Issue
- 5
- Pages
- 491-501
- ISSN
- 1741-8267 (ISSN-L)
- OpenAlex
- W2160970334
- Cited by
- 384
- References
- 43
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 13 · 2023: 12 · 2022: 16 · 2021: 28 · 2020: 23 · 2019: 25 · 2018: 16 · 2017: 38 · 2016: 36 · 2015: 43 · 2014: 24 · 2013: 33 · 2012: 34
- FWCI
- 28.09
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- European Journal of Cardiovascular Prevention & Rehabilitation (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- Murdoch University Research Portal (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Science Foundation
- Bristol-Myers Squibb
- Pfizer
- GlaxoSmithKline
- Gilead Sciences
- European Commission (BIOMED2, CT94-1637, CT97-2713, QLK2-2000-00773)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (U01AI046362, U01AI042170, U01AI069907)
- Cilag
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- cardiovascular risk prediction, HIV infection, antiretroviral therapy, highly active antiretroviral therapy, metabolic complications, myocardial infarction, coronary artery disease, indinavir, lopinavir/ritonavir, abacavir, Framingham risk score, cardiovascular risk factors
- MeSH terms
- Adult, Argentina, Australia, Coronary Disease, Drug Therapy, Combination, Europe, Female, Humans, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Risk Factors, Time Factors, Reproducibility of Results, Models, Statistical, HIV Infections, Treatment Outcome, Risk Assessment, Anti-HIV Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
